Voyager Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC VYGR

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/13/2026

Shares

595

Value ($000)

2

Weight

0.0%

2019 Q4 - 2026 Q1 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/13/2026	2	0.0%	595	3/31/2026
2022 Q4	2/14/2023	298	0.0%	48,900	12/31/2022
2021 Q1	5/14/2021	124	0.0%	26,231	3/31/2021
2020 Q4	3/1/2021	100	0.0%	14,009	12/31/2020
2020 Q3	11/13/2020	149	0.0%	14,009	9/30/2020
2020 Q2	8/14/2020	177	0.0%	14,009	6/30/2020
2020 Q1	5/15/2020	128	0.0%	14,009	3/31/2020
2019 Q4	2/14/2020	4,101	0.0%	293,976	12/31/2019